
A new approach to preventing gout attacks looks promising for people not already helped by existing treatments. Researchers are looking at an anti-inflammatory drug called canakinumab (Ilaris) to treat this painful form of arthritis. Instead of targeting excessively high uric acid levels as existing gout drugs do, the new strategy aims to reduce overall inflammation.… read on >